Obesity Management: ENDO 2017 Highlights

April 06, 2017

Could corticosteroid use put your patients at a greater risk of metabolic syndrome?

Endo 2017: Improve Diabetes, Obesity Care

April 04, 2017

Three studies from ENDO 2017 focused on improving patient care through brain stimulation, an artificial pancreas system, and videoconferencing.

Endo 2017: Men’s Health

April 04, 2017

Men’s health studies presented at ENDO 2017 included a possible prostate cancer treatment and the potential of hormone therapy to prevent frailty.

Can We Suppress Sugar Cravings?

April 03, 2017

Researchers sought to discover the specific physiological pathways of fibroblast growth factor 21.

Clinical Dilemmas in Diabetes

April 03, 2017

Research presented at ENDO 2017 explored options to reduce complications in patients with diabetes and microalbuminuria and patients with cystic fibrosis.

Role of the Striatum in Obesity

April 02, 2017

Researchers investigated possible differences in the function of the striatum both before and after the development of obesity.

ENDO 2017: Sleep Studies

April 02, 2017

Studies presented at ENDO 2017 examined the impact of sleep disorders on gestational diabetes, bone formation, and adolescents with and without diabetes.

ENDO 2017: Top Sessions

March 31, 2017

You won’t want to miss these top sessions and new features at this year’s Endocrinology Society’s annual meeting, April 1-4, in Orlando, FL.

ENDO 2016: Women’s Health – Part 2

April 27, 2016

To continue our coverage of women’s health from ENDO 2016, we summarize findings on bone mass loss and asthma in polycystic ovary syndrome.

Developments in Type 2 Diabetes Management

April 18, 2016

Findings presented at ENDO 2016 shed some light on developments that could play a role in type 2 diabetes prevention, treatment, and management.